FDA Investigator Douglas G Ng
Douglas G Ng has conducted inspections on 43 sites in 1 countries as of 22 Apr 2013. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
43
Last Inspection Date:
22 Apr 2013
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Douglas G Ng:
Alia Legaux,
Alice S Tsao,
Althea A Williams,
Alysia M Salonia,
Amatul H Marium,
Amber D Brodas,
Amber G Chung,
Amber I Jessup,
Amy Constantine,
Amy Wyan Mai,
Andrew F Cohen,
Andrew J Garufi,
Angela Jourdain,
Anthony R Rauert,
Arduino Frankovic,
Arthur S Williams, Jr,
Ashley M Whitehurst,
Ashley Polizzotto,
Brian R Yaun,
Carrie L Doupnik,
Charisse K Green,
Charles E Idjagboro,
Christian Parra,
Christine M Rivera,
Christopher S Fields,
Daniel Green,
Dave M Deroche,
Dawn M Mccabe,
Dennis L Doupnik,
Dianiris C Ayala,
Dianne H Milazzo,
Dipesh K Shah,
Dolores Harper,
Donald J Ullstrom,
Douglas A Campbell,
Dr. Robert C Horan, MD,
Edward P Potter,
Elizabeth P Mayer,
Emilio Z Azukwu,
Erica B Brush,
Erica B Raphael,
Evelyn Taha,
Frank Verni,
Gale L Glinecki,
Gregson A Joseph,
Iqra Iftikhar,
Iram R Hassan, PhD,
Irina Gaberman,
Jacqueline S Warner,
James A Liubicich,
Jamie D Richardson,
Janaysia N Trail,
Jane C Chen,
Jason Kwong,
Jay T Wong,
Jessica D Weber,
Jody E Robinson,
John E Aghadia,
John P Sakowski,
Jose Ohernandez Guzman,
Jose V Obando,
Joseph Maselli,
Joseph Milcetic,
Joy P Matthias,
Joyce A Williams,
Judy Keihl,
Juliana Falla,
Jung K Kim,
Karen L Kosar,
Kerry D Noto,
Kimberley A Ricketts,
Kirk A Dymbrowski,
Kwong P Lee,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Lisa Mathew,
LTJG Matthew R Palo,
Manhar R Patel,
Mary M Finn,
Melissa N Gregorio,
Mercedes G Castillo,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael R Dominick,
Michele C Murray Schrade,
Milan S Kunajukr,
Milan S Mcgorty,
Miral B Patel,
Morgan J Matthews,
Morris Paul,
Mouhamed H Halwani,
Nancy A Saxenian Emmons,
Neil J Bonzagni, PhD MPH,
Nur M Faisal,
Patrick C Klotzbuecher,
Pearl L Gonzalez,
Perez,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Peter S Diak,
Preston M Lee,
Rachael A Moliver,
Raymond M Lam,
Richard K Vogel,
Robert C Steyert,
Robert E Moncayo,
Robert P Neligan,
Ronald Ifraimov,
Rose Xu,
Sarah A Meehan,
Sarah A Wangseng,
Satheesh Thomas,
Shamel Jaime,
Sonia D Hudson,
Stephanie T Durso,
Steven J Libal,
Sunita Vij,
Tamara M Simpson,
Tammy M Phillips,
Tara K Carmody,
Tara K Normandin,
Tracy M Portelli,
Uduak M Inokon,
Valerie A Potopsingh,
Valerie Jgrecek Trinh,
Vivin George,
Willy A Orantes,
Winston R Alejo,
Xiaokuang Lai, PhD,
Yuyan Liang,
Yvesna C Blaise
Douglas G Ng's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2009 | EIR | Setton International Foods, Inc. - EIR, 2009-01-27 |
February, 2010 | FDA 483 | Amneal Pharmaceuticals of New York, LLC - Form 483, 2010-02-05 |
May, 2013 | EIR | Abbott Laboratories - EIR, 2013-05-14 |
October, 2009 | FDA 483 | J.R. Rand Corp. - Form 483, 2009-10-02 |
May, 2013 | FDA 483 | Abbott Laboratories - Form 483, 2013-05-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more